Alterations in calcitonin and parathyroid hormone responsiveness of adenylate cyclase in F9 embryonal carcinoma cells treated with retinoic acid and dibutyryl cyclic AMP.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D002116:Calcitonin / Q000378:metabolism*; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D005260:Female; D007545:Isoproterenol / Q000494:pharmacology; D051379:Mice; D010281:Parathyroid Hormone / Q000378:metabolism*; D011247:Pregnancy; D013724:Teratoma / Q000201:enzymology*; D014212:Tretinoin / Q000494:pharmacology*
D010281:Parathyroid Hormone; D014212:Tretinoin; D003994:Bucladesine; D002116:Calcitonin; D000262:Adenylyl Cyclases; D007545:Isoproterenol